| FUND CLASS | NAV | SINCE PREVIOUS MONTH | THIS YEAR | SINCE FUND START | START DATE |
| IC1 (EUR) | 663.00 | -3.73% | -0.46% | 563.00% | 2009-06-22 |
| IC3 (EUR) | 795.41 | -3.67% | 0.26% | 695.41% | 2009-07-31 |
| IC2 (SEK) | 495.17 | -4.90% | -1.80% | 395.17% | 2012-12-31 |
| ID1 (SEK) | 344.14 | -4.94% | -7.20% | 244.14% | 2012-04-30 |
| IC1 (USD) | 176.32 | 1.10% | 4.49% | 76.32% | 2015-01-31 |
| IC2 (USD) | 239.75 | 1.13% | 4.76% | 139.75% | 2014-04-30 |
| RC1 (EUR) | 575.10 | -3.77% | -0.74% | 475.10% | 2010-08-31 |
| RC1 (SEK) | 591.99 | -4.98% | -2.30% | 491.99% | 2009-06-22 |
| RC2 (SEK) | 621.88 | -4.94% | -2.06% | 521.88% | 2009-06-22 |
| FUND CLASS | NAV | SINCE PREVIOUS MONTH | THIS YEAR | SINCE FUND START | START DATE |
| RC1 (SEK) | 81.53 | -3.00% | -21.68% | -18.47% | 2016-08-31 |
| RC9 (SEK) | 85.63 | -2.89% | -21.10% | -14.37% | 2016-08-31 |
| IC1 (EUR) | 74.18 | -1.72% | -20.14% | -25.82% | 2017-06-30 |
Rhenman Healthcare Equity L/S
("RHE L/S")
RHE L/S is a global, long-biased hedge fund that invests in the healthcare sector. Since RHE L/S was launched in June 2009, it has returned + 563 %, which corresponds to an annual average of + 19 %. RHE L/S is managed by an experienced management team and supported by the Scientific Advisory Board. Read more >
Rhenman Global Opportunities L/S
("RGO L/S")
RGO L/S is an actively managed global hedge fund with a long bias over a business cycle. The investment horizon for long investments is 2–4 years and for short investments 6–24 months. The fund makes its investments based on active choices of regions and sectors, independent of indices. The fund is managed by an experienced manager with the support of an advisory board. Read more >
Rhenman & Partners Asset Management
Founded in 2008, Rhenman & Partners Asset Management is a Stockholm-based asset manager focusing on two niche funds: Rhenman Healthcare Equity L/S (RHE L/S), founded in 2009, and Rhenman Global Opportunities L/S (RGO L/S), launched on August 31, 2016. The funds are managed by FundRock Management Company SA. Read more >
The fund managers Henrik and
Susanna discuss the healthcare fund
Rhenman Healthcare Equity L/S is celebrating its 10-year anniversary, and the fund’s two managers talk about the fund’s strategy, focus and expectations. The fund has returned an average of +19% per annum during the 10 years RHE L/S has been active. Susanna highlights four areas that explain this success. Henrik shares his thoughts on the future of the healthcare sector and what to expect from the fund in the coming years.
Staffan Knafve describes Rhenman Global Opportunities L/S
Started in 2017, Rhenman Global Opportunities L/S is a global hedge fund that goes against the tide. Staffan and Pontus describe the fund’s philosophy, which is primarily value-oriented. The fund avoids following the flow of index funds that invest widely in tech and other growth stocks. Instead, the focus is to invest selectively in equities, industries and regions that have advantageous fundamentals and indicators.
Keep up-to-date
Keep yourself updated by reading our monthly letters: Rhenman Healthcare Equity L/S and Rhenman Global Opportunities L/S. Read more >
The Scientific Advisory Board
An important reason behind our funds’ great success is the co-operation between the portfolio managers and the medical experts on our Scientific Advisory Board. Read more >
Rhenman Healthcare Equity L/S
Fund development - IC1 (EUR)
Healthcare – a sector with great potential
For several decades, the healthcare sector has accounted for a rising share of the world’s GDP. In the US, the share has risen to + 19 % of GDP. In the OECD countries, the average is 12%. In emerging markets, such as China and India, shares of GDP are rising quickly, which means there is great potential. Read more >
Read more >
Latest news
- 23 January 2020 The Best Performers of 2019 -HedgeNordic
- 07 July 2019 Best performing hedge fund in Europe- Article in Financial Times
- 15 April 2019 Rhenman & Partners wins prestigious award at the Nordic Hedge Awards: Best Performance Awards for 5 Years
- 15 April 2019 Performance Award for 60 Months: Rhenman Healthcare Equity L/S
- 11 April 2019 Riding Markets While Shorting Market Darlings